🇺🇸 FDA
Patent

US 12121526

Targeting NCCA-ATP channel for organ protection following ischemic episode

granted A61KA61K31/427A61K31/565

Quick answer

US patent 12121526 (Targeting NCCA-ATP channel for organ protection following ischemic episode) held by United States Government as represented by the Department of Veterans Affairs expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/427, A61K31/565, A61K31/57, A61K31/64